Prostate cancer kills even the strongest of men. The disease accounts for over 30,000 deaths to American men in a year. It is the second major source of cancer deaths for men in the US – next to lung cancer. Not only is prostate cancer highly fatal but also it can be extremely difficult to diagnose.
Doctors, physicians, and other medical experts in the field have no accurate techniques and procedures to determine the fatality of a certain prostate tumor. Due to such problems, a number of studies have been made to help medical experts properly determine whether a certain prostate cancer tumor is fatal or not.
Recently, scientists have discovered a new procedure that increases that accuracy of determining such dangerous tumors.
Testing the behavior of certain genes in the prostate tumors has given this new test a 7 percent boost in accuracy compared with the current testing methods. This finding brings 91 percent accuracy.
The Wall Street Journal was told by Dr. Charles Sawyer, a cancer expert at Memorial Sloan Kettering Cancer Center in New York City, that this technology would have a huge impact if it be widely available in the medical industry.